Back to Journals » Drug Design, Development and Therapy » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,515 | Dovepress* | 5,950+ | 827 | 6,777 | |
PubMed Central* | 565 | 176 | 741 | ||
Totals | 6,515 | 1,003 | 7,518 | ||
*Since 24 August 2020 |
View citations on PubMed Central and Google Scholar